{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-025469","form_type":"8-K","ticker":"BCTX","cik":"0001610820","company_name":"BriaCell Therapeutics Corp.","filed_at":"2025-12-01T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.914471+00:00","generated_at":"2026-05-16T15:53:07.134744+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"BriaPro subsidiary reports $740K loss; going concern doubt flagged by auditor","bullets":["BriaPro net loss $740,216 for year ended July 31, 2025, accumulated deficit $1,180,425.","Auditor's report includes material uncertainty about BriaPro's ability to continue as a going concern.","BriaPro has $1 cash, $1.15M current liabilities, and total assets of $184,526 primarily intangible assets.","Subsidiary wholly dependent on BriaCell for financing; no commercial operations yet."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-025469","json":"https://secwatch.observer/filing/0001493152-25-025469.json","markdown":"https://secwatch.observer/filing/0001493152-25-025469.md","text":"https://secwatch.observer/filing/0001493152-25-025469.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1610820/000149315225025469/0001493152-25-025469-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1610820/000149315225025469/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T15:53:07.134744+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}